←Back to Expert Scholars
Translational Medicine / 转化医学Cytoreductive Surgery, Peritoneal Malignancies
Marcelo Deraco
MD
🏢Fondazione IRCCS Istituto Nazionale dei Tumori🌐Italy
Director, Peritoneal Malignancies Unit
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Marcelo Deraco pioneered CRS and HIPEC for peritoneal mesothelioma and gynecologic peritoneal disease. His long series of peritoneal malignancy surgery set European standards. He directs the peritoneal malignancy unit at INT Milan.
Share:
🧪Research Fields 研究领域
CRS HIPEC
peritoneal mesothelioma
ovarian cancer HIPEC
peritoneal carcinomatosis
cytoreductive surgery
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Marcelo Deraco 的研究动态
Follow Marcelo Deraco's research updates
留下邮箱，当我们发布与 Marcelo Deraco（Fondazione IRCCS Istituto Nazionale dei Tumori）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment